The boom in counterfeit obesity drugs

Detection of Illicit Content on Online Marketplaces using Large Language Models

Adverse events associated with use of immunoglobulin in pediatric patients reported to the US Food and Drug Administration Adverse Event Reporting System, 2001-2023

Economic evaluation of anti-malarial drug policies across presidential regimes in Nigeria: A comparative analysis from 1999 to present

Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK: A Nested Case–Control and Case‐Crossover Study

Trends and Patterns of Adverse Drug Reaction Reporting in Sierra Leone: A Retrospective Analysis of VigiFlow Data (2008–2022)

Preventability of Antibiotic-Associated Adverse Drug Reactions Reported to a Regional Pharmacovigilance Center: A Cross-Sectional Descriptive Study

Adverse Childhood Experiences and Treatment-Resistant Depression

Meningitis Risk for Young Adults With Chikungunya Vaccine

INFORME RACIM. Actualización sobre medicamentos retirados por motivos de seguridad en otros países y su permanencia en Argentina

GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK: A Nested Case–Control and Case‐Crossover Study

IMPLEMENTATION OF ACTIVE PHARMACOVIGILANCE SYSTEMS IN HEALTH SERVICES AND PHARMACEUTICAL INDUSTRIES: A CRITICAL ANALYSIS OF ANVISA’S REQUIREMENTS

Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants

Profeco y Cofepris alertan por comercialización ilegal de productos con Tirzepatida

FDA - Novo Nordisk Inc. – Warning Letter

FDA Launches New Adverse Event Look-Up Tool

Drug-associated Torsades de Pointes and QT Prolongation in Infants: A Focused Real-World Disproportionality Analysis Pharmacovigilance Study.

A multi-state cross-sectional assessment of essential medicine availability in Sudan during armed conflict

Señales de notificación desproporcionada de eventos supuestamente atribuibles a las vacunas contra la covid-19 en niños y adolescentes: estudio de casos/no casos, Brasil, 2022

Comparing infectious risk of Trastuzumab-deruxtecan to Trastuzumab-emtansine in patients with breast cancer

Building pharmacovigilance-ready datasets from resource-limited settings: Study of antiretroviral-associated ADRs in Melanesian patients

Reclaiming Pharmacovigilance: Bridging the Evidence–Practice Gap in Psychopharmacology

Data-driven medical devices and the EU MDR: mapping gaps in standards for regulatory compliance

FDA’s Regulatory Reforms to Unlock Competition and Lower Drug Costs Breaking the Biosimilar Bottleneck

Comparative Safety of Six First-Line Antiepileptic Monotherapies in Pediatric Epilepsy Using the United States FDA Adverse Event Reporting System

Surge el Centro Nacional de Farmacovigilancia y Tecnovigilancia (CENAFyT)

Long-term safety evaluation of mirtazapine: A real-world pharmacovigilance study based on the FAERS database

Data mining and analysis of adverse drug events of propofol in the general population and the elderly based on the US Food and Drug Administration Adverse Event Reporting System

La AEMPS publica el Informe Anual sobre Farmacovigilancia Veterinaria

“Is This Normal?”: Understanding and Managing Adverse Reactions

Two deaths reported to drug watchdog over potential link to weight-loss jabs

OTC Medications Expose Toddlers to Potentially Risky Parabens

Reducing drug failures with AI, human liver organoids